Serum NT pro-BNP: Relation to systolic and diastolic function in cardiomyopathies and pericardiopathies;Níveis séricos de NT pro-BNP: Relação com função sistólica e diastólica nas miocardiopatias e pericardiopatias

Arquivos Brasileiros de Cardiologia

Volumn 91, Issue 1, 2008, Pages 49-54

  Mady, Charles ^a,b   Fernandes, Fábio ^a   Arteaga, Edmundo ^a   Ramires, Felix José Alvarez ^a   Buck, Paula De Cássia ^a   Salemi, Vera Maria Cury ^a   Ianni, Barbara Maria ^a   Nastari, Luciano ^a   Dias, Ricardo Ribeiro ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b NONE   (Brazil)

Author keywords

Cardiomyopathies; Pericardial effusion; Pericarditis, constrictive

Indexed keywords

ADULT; ARTICLE; CARDIOMYOPATHY; CHAGAS DISEASE; CHEMOLUMINESCENCE; CONSTRICTIVE PERICARDITIS; CONTROLLED STUDY; DIASTOLIC DYSFUNCTION; ECHOCARDIOGRAPHY; FEMALE; HEART MUSCLE FIBROSIS; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MAJOR CLINICAL STUDY; MALE; MYOCARDIAL DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PERICARDIAL DISEASE; PERICARDIAL EFFUSION; SYSTOLIC DYSFUNCTION; BLOOD; CASE CONTROL STUDY; DIASTOLE; ECHOGRAPHY; HEART VENTRICLE FUNCTION; MIDDLE AGED; PATHOPHYSIOLOGY; PERICARDIUM; PHYSIOLOGY; PROSPECTIVE STUDY; RESTRICTIVE CARDIOMYOPATHY; SYSTOLE;

BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; PEPTIDE FRAGMENT; PRO BRAIN NATRIURETIC PEPTIDE (1 76); PRO-BRAIN NATRIURETIC PEPTIDE (1-76);

ADULT; BIOLOGICAL MARKERS; CARDIOMYOPATHIES; CARDIOMYOPATHY, HYPERTROPHIC; CARDIOMYOPATHY, RESTRICTIVE; CASE-CONTROL STUDIES; CHAGAS CARDIOMYOPATHY; DIASTOLE; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PERICARDIAL EFFUSION; PERICARDITIS, CONSTRICTIVE; PERICARDIUM; PROSPECTIVE STUDIES; SYSTOLE; VENTRICULAR DYSFUNCTION;

EID: 48249103947     PISSN: 0066782X     EISSN: 16784170     Source Type: Journal    
DOI: 10.1590/S0066-782X2008001300008     Document Type: Article

References (22)

1. Richardson P, McKenna W, Bristow M, Maisch B, Mautner B, O'Connell J, et al. Report of the 1995 WHO/ISFC Task Force on the definition and classification of cardiomyopathies. Circulation. 1996; 93: 841-2.
2. Mady C, Décourt LV. A forma indeterminada da doença de Chagas (editorial). Arq Bras Cardiol. 1981; 36: 143-5.
3. Ianni BM, Mady C. Aplicações clínicas do eletrocardiograma na miocardiopatia chagásica. Rev Soc Cardiol Estado de São Paulo. 1999; 9: 318-22.
4. Maron BJ. Hypertrophic cardiomyopathy. Lancet. 1997; 350: 127-33.
5. Kushhwara S, Fallon JT, Fuster V. Restrictive cardiomyopathy. N Engl J Med. 1997; 336: 267-76.
6. Fernandes F, Mady C, Vianna CB, Barretto AC, Arteaga E, Ianni BM, et al. Aspectos radiológicos da endomiocardiofibrose. Arq Bras Cardiol. 1997; 68: 269-72.
7. Sagrista Sauleda J. Clinical decision making based on cardiac diagnostic imaging techniques (I). Diagnosis and therapeutic management of patients with cardiac tamponade and constrictive pericarditis. Rev Esp Cardiol. 2003; 56: 195-205.
8. Dahlstrom U. Can natriuretic peptides be used for the diagnosis of diastolic heart failure? Eur J Heart Fail. 2004; 6: 281-7.
9. Richards AM. The natriuretic peptides in heart failure. Basic Res Cardiol. 2004; 99: 94-100.
10. Sahn D, DeMaria A, Kisslo J, Weyman A. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation. 1978; 58: 1072-83.
11. Devereux RB, Alonso DR, Lutas EM. Echocardiography assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol. 1986; 57: 450-8.
12. Teichholz LE, Kreulen T, Herman MV, Gorlin R. Problems in echocardiographic volume determinations: echocardiographic-angiographic correlations in the presence or absence of asynergy. Am J Cardiol. 1976; 37: 7-11.
13. Merce J, Sagrista-Sauleda J, Permanyer-Miralda G, Evangelista A, Soler-Soler J. Correlation between clinical and Doppler echocardiographic findings in patients with moderate and large pericardial effusion: implications for the diagnosis of cardiac tamponade. Am Heart J. 1999; 138 (4 Pt 1): 759-64.
14. Appleton CP, Jensen JL, Hatle LK, Oh JK. Doppler evaluation of left and right ventricular diastolic function: a technical guide for obtaining optimal flow velocity recordings. J Am Soc Echocardiogr. 1997; 10: 271-91.
15. Melo RB, Parente GB, Victor EG. Measurement of human brain natriuretic peptide in patients with Chagas' disease. Arq Bras Cardiol. 2005; 84: 137-40.
16. Ribeiro AL, dos Reis AM, Barros MV, de Sousa MR, Rocha AL, Perez AA, et al. Brain natriuretic peptide and left ventricular dysfunction in Chagas' disease. Lancet. 2002; 360: 461-2.
17. Ribeiro AL, Teixeira MM, Reis AM, Talvani A, Perez AA, Barros MV, et al. Brain natriuretic peptide based strategy to detect left ventricular dysfunction in Chagas disease: a comparison with the conventional approach. Int J Cardiol. 2006; 109: 34-40.
18. Nishigaki K, Tomita M, Kagawa K, Noda T, Minatoguchi S, Oda H, et al. Marked expression of plasma brain natriuretic peptide is a special feature of hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol. 1996; 28: 1234-42.
19. Schwartz SL, Pandian NG, Cao QL, Hsu TL, Aronovitz M, Diehl J. Left ventricular diastolic collapse in regional left heart cardiac tamponade: an experimental echocardiographic and hemodynamic study. J Am Coll Cardiol. 1993; 22: 907-13.
20. Kaszaki J, Nagy S, Tarnoky K, Laczi F, Vecsernyes M, Boros M. Humoral changes in shock induced by cardiac tamponade. Circulation. 1989; 29: 143-53.
21. Yazdani K, Maraj S, Amanullah AM. Differentiating constrictive pericarditis from restrictive cardiomyopathy. Rev Cardiovasc Med. 2005; 6: 61-71.
22. Leya FS, Arab D, Joyal D, Shioura KM, Lewis BE, Steen LH, et al. The efficacy of brain natriuretic peptide levels in differentiating constrictive pericarditis from restrictive cardiomyopathy. J Am Coll Cardiol. 2005; 45: 1900-2.